Balefire LLC lifted its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 165.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,037 shares of the company's stock after acquiring an additional 3,759 shares during the period. Balefire LLC's holdings in Procter & Gamble were worth $962,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of PG. Nova Wealth Management Inc. acquired a new stake in shares of Procter & Gamble during the 1st quarter worth approximately $26,000. Capital A Wealth Management LLC acquired a new stake in Procter & Gamble during the fourth quarter worth $31,000. Quarry LP acquired a new stake in Procter & Gamble during the first quarter worth $33,000. 10Elms LLP acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at about $34,000. Finally, Mizuho Securities Co. Ltd. boosted its position in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Stock Performance
Procter & Gamble stock opened at $158.08 on Wednesday. The company's 50-day moving average is $156.14 and its two-hundred day moving average is $161.62. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a market cap of $369.98 billion, a PE ratio of 24.28, a PEG ratio of 4.14 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were paid a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio is presently 64.98%.
Analysts Set New Price Targets
PG has been the topic of a number of recent research reports. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a report on Thursday, July 31st. UBS Group set a $180.00 price target on Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, BNP Paribas restated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus price target of $175.12.
Get Our Latest Analysis on Procter & Gamble
Insider Transactions at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the sale, the chief executive officer owned 319,375 shares in the company, valued at approximately $50,228,106.25. This trade represents a 11.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 120,181 shares of company stock valued at $18,918,012. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.